Paul Hastings Advised Raymond James in U.K.-Based Zura Bio Limited’s Cross-Border Business Combination with JATT Acquisition Corp
Paul Hastings LLP advised Raymond James as financial advisor in connection with U.K. clinical-stage biotechnology company Zura Bio Limited’s de-SPAC merger with JATT Acquisition Corp. As a result of the merger, the combined company’s shares are trading on Nasdaq under the ticker “ZURA.”
This successful listing by a U.K. company on Nasdaq demonstrates the continued success of Paul Hastings’ cross-border capital markets offering.
Los Angeles partner Jonathan Ko and London partner Max Kirchner led the cross-office Paul Hastings team, which also included associates Amir Heyat and Diana Balassiano.
About Paul Hastings
With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment and real estate, Paul Hastings is a premier law firm providing superior intellectual capital and execution globally to the world’s leading investment banks, asset managers and corporations.
With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world's leading investment banks, asset managers and corporations.